Colgate-Palmolive Firm (NYSE:CL) is included among the many 11 Best Rising Dividend Stocks to Buy Right Now.
On Might 5, Barclays raised its worth advice on Colgate-Palmolive Firm (NYSE:CL) to $80 from $79. It reiterated an Equal Weight score on the shares. The agency stated it believes the corporate is specializing in attaining a greater steadiness between pricing and quantity development in 2026.
A couple of days earlier, on Might 2, Goldman Sachs raised its worth objective on Colgate-Palmolive to $100 from $98. It maintained a Purchase score on the inventory. The agency pointed to the corporate’s stronger-than-expected Q1 outcomes, with each income and earnings coming in forward of expectations. In accordance with the analyst, natural gross sales development was increased than anticipated, whereas broad-based power throughout the enterprise additionally supported barely better-than-expected gross margins. Goldman Sachs added that EBIT margins remained consistent with expectations whilst promoting spending elevated 10% throughout the quarter.
Colgate-Palmolive Firm (NYSE:CL) focuses on oral care, private care, house care, and pet diet merchandise.
Whereas we acknowledge the potential of CL as an funding, we consider sure AI shares supply larger upside potential and carry much less draw back danger. In the event you’re in search of an especially undervalued AI inventory that additionally stands to profit considerably from Trump-era tariffs and the onshoring pattern, see our free report on the best short-term AI stock.
READ NEXT: 12 Best Micro-Cap Dividend Stocks To Buy Now and 10 Best Stocks to Buy Now for a $1 Million Portfolio
Disclosure: None. Follow Insider Monkey on Google News.
